News Covid-19: Novavax vaccine exhibits 89% efficacy in UK trials By Nancy Carrillo Last updated Jan 29, 2021 Share The Novavax shock is the first to show it is effective against the British variant of the virus. COVID19efficacyNovavaxShowstrialsVaccine Share FacebookTwitterGoogle+ReddItWhatsAppPinterestEmail
Comments are closed.